Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
This phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to smoke, step-by-step guides for quitting smoking, help in planning for quitting and staying tobacco-free, and scientifically-based recommendations for how to select medications that aid in smoking cessation.
Hematopoietic and Lymphoid System Neoplasm|Malignant Solid Neoplasm
BEHAVIORAL: Quit2Heal|BEHAVIORAL: QuitGuide|OTHER: Survey Administration
Number of participants with 30-day cigarette smoking cessation at 12 months., No smoking at all in the past 30 or more days., At 12 months after randomization
Number of participants with 30-day cigarette smoking cessation at 3 months., No smoking at all in the past 30 or more days., At 3 months after randomization|Number of participants with 30-day cigarette smoking cessation at 6 months., No smoking at all in the past 30 or more days., At 6 months after randomization
OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive the Quit2Heal app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.

ARM II: Patients receive the QuitGuide app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.

After randomization, patients are followed up at 3, 6, and 12 months.